MX2022004262A - Composiciones de cannabinoides para usarse en mejorar la salud, metodos de fabricacion y uso de las mismas. - Google Patents

Composiciones de cannabinoides para usarse en mejorar la salud, metodos de fabricacion y uso de las mismas.

Info

Publication number
MX2022004262A
MX2022004262A MX2022004262A MX2022004262A MX2022004262A MX 2022004262 A MX2022004262 A MX 2022004262A MX 2022004262 A MX2022004262 A MX 2022004262A MX 2022004262 A MX2022004262 A MX 2022004262A MX 2022004262 A MX2022004262 A MX 2022004262A
Authority
MX
Mexico
Prior art keywords
compositions
methods
enhancing health
wellbeing
enhancing
Prior art date
Application number
MX2022004262A
Other languages
English (en)
Inventor
William Kleidon
Original Assignee
Ojai Energetics Pbc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ojai Energetics Pbc filed Critical Ojai Energetics Pbc
Publication of MX2022004262A publication Critical patent/MX2022004262A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/01—Hydrocarbons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/01—Hydrocarbons
    • A61K31/015—Hydrocarbons carbocyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
    • A61K31/105—Persulfides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

Las composiciones, métodos y equipos descritos en la presente pueden formularse como un suplemento nutricional o un suplemento dietético. La composición descrita en la presente puede proporcionar nutrientes o compuestos que de otro modo no se consumirían en cantidades suficientes en una dieta normal, y pueden contribuir al bienestar físico y al bienestar emocional de un sujeto.
MX2022004262A 2017-03-30 2019-09-26 Composiciones de cannabinoides para usarse en mejorar la salud, metodos de fabricacion y uso de las mismas. MX2022004262A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201762479091P 2017-03-30 2017-03-30
US201762506475P 2017-05-15 2017-05-15
US201862632965P 2018-02-20 2018-02-20

Publications (1)

Publication Number Publication Date
MX2022004262A true MX2022004262A (es) 2022-05-06

Family

ID=63676925

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2019011510A MX2019011510A (es) 2017-03-30 2018-03-23 Metodos y composiciones para mejorar la salud.
MX2022004262A MX2022004262A (es) 2017-03-30 2019-09-26 Composiciones de cannabinoides para usarse en mejorar la salud, metodos de fabricacion y uso de las mismas.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
MX2019011510A MX2019011510A (es) 2017-03-30 2018-03-23 Metodos y composiciones para mejorar la salud.

Country Status (11)

Country Link
US (1) US20200101041A1 (es)
EP (1) EP3600271A4 (es)
JP (2) JP2020512358A (es)
CN (1) CN110709069A (es)
AU (1) AU2018243694A1 (es)
BR (1) BR112019020554A2 (es)
CA (1) CA3057994A1 (es)
GB (1) GB2577810A (es)
IL (1) IL269642A (es)
MX (2) MX2019011510A (es)
WO (1) WO2018183115A1 (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10239808B1 (en) 2016-12-07 2019-03-26 Canopy Holdings, LLC Cannabis extracts
GB2571696B (en) 2017-10-09 2020-05-27 Compass Pathways Ltd Large scale method for the preparation of Psilocybin and formulations of Psilocybin so produced
US11202771B2 (en) 2018-01-31 2021-12-21 Treehouse Biotech, Inc. Hemp powder
US20210030777A1 (en) * 2018-04-04 2021-02-04 Vinsan Therapeutics Inc. Topical formuations and instillates, kits, and methods for treating integumentary wounds, and uses thereof
EP3793542A4 (en) * 2018-05-14 2022-03-30 Buzzelet Development And Technologies Ltd TERPENE-ENRICHED CANNABINOID COMPOSITIONS AND THEIR USES IN THE TREATMENT OF INFECTIOUS DISEASES
EP3864000A4 (en) 2018-10-10 2022-08-10 Treehouse Biosciences, Inc. CANNABIGEROL SYNTHESIS
WO2020084450A1 (en) * 2018-10-23 2020-04-30 Radient Technologies Innovations Inc. Method of automating cannabis decarboxylation and extraction by recursive decarboxylation, sampling, and extraction steps
WO2020084425A1 (en) * 2018-10-24 2020-04-30 Radient Technologies Innovations Inc. Side effect and symptom relief
US10609944B1 (en) 2018-12-14 2020-04-07 Natural Extraction Systems, LLC Compositions comprising 2-[(1R,6R)-6-isopropenyl-3-methylcyclohex-2-en-1-yl]-3-hydroxy-5-pentylphenolate and 2-[(1R,6R)-6-isopropenyl-3-methylcyclohex-2-en-1-yl]-5-pentylbenzene-1,3-diol
US10959961B2 (en) * 2018-12-14 2021-03-30 Natural Extraction Systems, LLC Methods of administering anionic cannabinoid molecules dissolved in water
WO2020212948A1 (en) 2019-04-17 2020-10-22 Compass Pathfinder Limited Methods of treating neurocognitive disorders, chronic pain and reducing inflammation
US11622956B1 (en) 2019-06-26 2023-04-11 RCR BioPharma Compound and method for treating diseases and disorders
WO2021016710A1 (en) * 2019-07-30 2021-02-04 Tassili Life Sciences, Corp. Controlled release formulations of multiple active pharmaceutical agents, and psilocybe-derived agents in combination with cannabis-derived agents and methods for their use
US10780075B1 (en) * 2019-07-31 2020-09-22 Etain IP, LLC Water soluble cannabis composition
CN117598506A (zh) 2019-09-12 2024-02-27 努利希尔有限公司 受控释放的核-壳粒子及包含其的悬浮液
US20220362319A1 (en) * 2021-05-12 2022-11-17 PPM Labs LLC Cannabinoid Concentration Process

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2400319B (en) * 2001-05-04 2005-06-08 Gw Pharma Ltd Cannabinoid-rich extracts
CA2904968A1 (en) * 2013-03-14 2014-10-02 Sc Laboratories, Inc. Bioactive concentrates and uses thereof
EP3062774A2 (en) * 2013-10-31 2016-09-07 Full Spectrum Laboratories, Ltd. Terpene and cannabinoid formulations
EP3209312A1 (en) * 2014-10-21 2017-08-30 United Cannabis Corp. Cannabis extracts and methods of preparing and using same
EP3250200A4 (en) 2015-01-31 2018-09-19 Constance Therapeutics, Inc. Methods for preparation of cannabis oil extracts and compositions
US20160250270A1 (en) * 2015-02-27 2016-09-01 Ebbu, LLC Compositions comprising combinations of purified cannabinoids, with at least one flavonoid, terpene, or mineral
US9747740B2 (en) * 2015-03-02 2017-08-29 Ford Global Technologies, Llc Simultaneous button press secure keypad code entry
CN109152748A (zh) * 2016-05-06 2019-01-04 哈维斯特·迪莱科特企业有限公司 口服大麻药物的制造方法、组合物和医学应用
CN109843287A (zh) * 2016-08-03 2019-06-04 塞尔达治疗手术有限公司 大麻属组合物
US20180344786A1 (en) * 2017-06-06 2018-12-06 NC3 Systems System and method enhanced cannabiniod effect delivery
PE20200731A1 (es) * 2017-09-28 2020-07-23 Canopy Growth Corp Composiciones de cannabinoides comestibles

Also Published As

Publication number Publication date
US20200101041A1 (en) 2020-04-02
MX2019011510A (es) 2020-01-09
GB201914076D0 (en) 2019-11-13
JP2020512358A (ja) 2020-04-23
IL269642A (en) 2019-11-28
CA3057994A1 (en) 2018-10-04
WO2018183115A1 (en) 2018-10-04
EP3600271A1 (en) 2020-02-05
JP2023139315A (ja) 2023-10-03
CN110709069A (zh) 2020-01-17
BR112019020554A2 (pt) 2020-04-28
GB2577810A (en) 2020-04-08
AU2018243694A1 (en) 2019-10-17
EP3600271A4 (en) 2020-12-16

Similar Documents

Publication Publication Date Title
MX2022004262A (es) Composiciones de cannabinoides para usarse en mejorar la salud, metodos de fabricacion y uso de las mismas.
MX2022012374A (es) Composiciones multi-suplementos.
IN2012DN00282A (es)
PH12015501688A1 (en) Nutritional compositions containing magnesium threonate and uses thereof
MX2016011898A (es) Composiciones de compuestos selenoorganicos y metodos de uso de los mismos.
MX2013005406A (es) Composicion nutricional adaptada a la edad con grasas animales y grasas vegetales.
PH12018500994A1 (en) Nutritional compositions containing butyrate and uses thereof
EA033540B1 (ru) Композиция, включающая окру, для применения в уменьшении абсорбции пищевого жира
MX369699B (es) Ácido graso del aceite de bogol para uso en suplementos y composiciones de tratamiento y piensos para animales.
MX2018015731A (es) Ingredientes de pienso que comprenden celulas microbianas lisadas.
MX2013012136A (es) Composiciones que comprenden un antimetabolito de glucosa y selenio.
PH12019550209A1 (en) A nutritional composition for use to enhance attention and/or reduce impulsivity
PH12017500203B1 (en) Nutritional composition for use in promoting gut and/or liver maturation and/or repair
MX2017010852A (es) Suplementos naturales enriquecidos por minerales.
SG11201901114TA (en) Plant, method for producing plant, tolerance imparting method, tomato and method for producing tomato
PH12016501947A1 (en) Gender specific synthetic nutritional compositions and nutritional systems comprising them
MX2018002531A (es) Metodos para aumentar la absorcion de vitaminas liposolubles en la alimentacion.
PH12019502354A1 (en) Composition containing a chloride salt for use in pregnant animals
MX2017008668A (es) Composicion de alimentos y metodo de uso.
EA201992271A1 (ru) Способы и композиции для улучшения здоровья
PH22017001036Y1 (en) Food supplement for the nervous system
MX2021010210A (es) Una composicion nutricional para usar para mejorar la funcion ejecutiva.
MX2019004082A (es) Composiciones farmaceuticas para incrementar el deseo sexual en hombres.
PH12013000374A1 (en) A novel composition
MX2020007171A (es) Mezcla de nutrientes para beneficios de salud en animales.